With the Moderna (NASDAQ:MRNA) share price blasting up, have the forward-looking markets got it right?

The Moderna (NASDAQ: MRNA) share price is going gangbusters as the world awaits results of its COVID-19 vaccine trial. Let's take a look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Moderna Inc (NASDAQ: MRNA) share price went like gangbusters yesterday, overnight Aussie time. The US biotech company's share price leapt 10.8%. And its up another 3.8% in afterhours trading.

This comes as investors eagerly anticipate the outcome of the final analysis of Moderna's promising COVID-19 vaccine trial.

Earlier this month, Moderna joined Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) in a globally exclusive club when the company announced its vaccine looked to be 95% effective in its extensive trial. One which encompassed 30,000 people.

Moderna's share price is now up 62% so far in November, and 468% so far in 2020. At the current share price, Moderna has a market cap of $48 billion.

small figure representing ASX shares with cape and shield fighting coronavirus

Image source: Getty Images

What does Moderna do?

Based in the United States city of Cambridge, Massachusetts, Moderna is a biotechnology company. The company focuses on developing and discovering new drugs and vaccine technologies based on messenger RNA. Moderna's technology platform inserts synthetic mRNA into human cells.

Why did the Moderna's share price leap 11% overnight?

Moderna's share price has been steadily moving higher on a series of positive announcements from the company.

Among those, the US has committed to buying 100 million doses of its vaccine, mRNA-1273, provided it wins emergency use approval. And it's not just the US.

Japan has agreed to buy 50 million doses, Canada wants 20 million and, in the latest development, the European Commission agreed to buy 80 million doses with an option to double that to 160 million. That agreement remains subject to European approval of the vaccine.

The 10.8% share price leap overnight comes as Moderna expects to release the final data from its expansive trial within the next week. Should the vaccine's efficacy prove to be in the 94.5% range as initially reported, Moderna will then file for emergency use authorisation with the US Food and Drug Administration (FDA).

If it gains approval, Moderna's vaccine could begin mass distribution just as global infection rates are rocketing to new levels. Hence the big share price surge.

Share markets are said to be forward looking. Meaning they anticipate tomorrow's news today.

With more than 588,000 new infections reported on Tuesday, 24 March, and global cases exceeding 60.2 million with 1.4 million fatalities, let's all hope the market's got this one right!

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup.
Share Gainers

Here are the top 10 ASX 200 shares today

Another day, another loss for investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Capstone Copper, Gentrack, Mineral Resources, and WiseTech shares are racing higher today

These shares are avoiding the market weakness and pushing higher. Let's find out why.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another rough day for the markets this Wednesday.

Read more »

people looking through comical glasses, what to look for, reporting season, person thinking, person interested
Share Gainers

Are APA shares a buy after reaching a three-year high?

Can the share price keep storming higher in 2026?

Read more »

A service station attendant crosses his arms and smiles towards the camera with a backdrop of petrol bowsers and a drive-through facility.
Energy Shares

Ampol shares surge 50% to a two-year high: Buy, sell or hold?

Find out what upside analysts are tipping for Ampol shares next.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why 29Metals, Aurelia Metals, Codan, and oOhMedia shares are racing higher today

These shares are faring better than most on hump day. What's going on?

Read more »

A male ASX investor on the street wearing a grey suit clenches his fist and yells yes after seeing on his ipad that the Paladin share price is going up again today
Share Market News

If I'd put $6K in this ASX mining stock 12 months ago I'd have over $20k now

Analysts tip the ASX miner's share price to climbing higher over the next 12 months.

Read more »